Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 5:22 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 97–120 of 167 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pain, Inflammatory Clear all

Conditions: Recurrent Acute Pancreatitis, Chronic Pancreatitis
Interventions: Soy-tomato juice product, Will include a soy-tomato juice product to be consumed during the 4 week intervention phase. A total of about 12 ounces (administered in two small cans) of the juice will be consumed; Dietary Supplement
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Osteoarthritis of the Knee
Interventions: ABT-652 NSAID, Placebo NSAID; Drug
Lead sponsor: AbbVie (prior sponsor, Abbott); Industry
Eligibility: 40 Years to 75 Years
Enrollment: 202 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 31
States / cities: Phoenix, Arizona • Tucson, Arizona • Anaheim, California + 27 more

Conditions: Crohn's Disease, Abdominal Pain (AP)
Interventions: VR headset; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 70 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Migraine
Interventions: Treximet, Placebo; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Sleep, Pediatrics, Adenotonsillectomy
Interventions: Not listed
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 13 Years to 18 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Ulcerative Colitis, Digestive System Diseases, Colitis, Ulcerative, Colitis, Gastrointestinal Diseases, Inflammatory Bowel Diseases, Intestinal Diseases, Colonic Diseases, Autoimmune Disease, Abdominal Pain
Interventions: KHK4083, Placebo; Drug
Lead sponsor: Kyowa Kirin, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Greenville, South Carolina

Conditions: Crohn Disease, Insomnia, Sleep Disturbance, Pain, Inflammation
Interventions: Cognitive Behavioral Therapy for Insomnia; Behavioral
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Overweight, Obesity, Healthy Adults
Interventions: Acetaminophen, Placebo, Weight stigma vignette, Control vignette; Drug · Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Pain
Interventions: Not listed
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 16 Years to 90 Years
Enrollment: 2,007 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001 – 2019
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Joint Pain
Interventions: Cyplexinol, Placebo; Dietary Supplement · Other
Lead sponsor: University of Memphis; Other
Eligibility: 30 Years to 65 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Pain, Inflammation
Interventions: Ibuprofen, Placebo tablet; Drug
Lead sponsor: Martin Angst; Other
Eligibility: 18 Years to 60 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010
U.S. locations: 1
States / cities: Stanford, California

Conditions: Stomatitis
Interventions: Etanercept, Placebo; Drug
Lead sponsor: National Institute of Nursing Research (NINR); NIH
Eligibility: 16 Years and older
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2010
U.S. locations: 2
States / cities: Bethesda, Maryland • Greenville, South Carolina

Conditions: Intravitreal Injections, IVI
Interventions: Bromfenac, Artificial tears; Drug
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Colorectal Cancer, Diverticular Disease, Crohn Disease, Ulcerative Colitis
Interventions: PGx-guided post-operative pain management; Genetic
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years to 80 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Tibia Fracture
Interventions: Ibuprofen; Drug
Lead sponsor: Major Extremity Trauma Research Consortium; Other
Eligibility: 18 Years to 80 Years
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Spine Fusion, NSAID (Non-Steroidal Anti-Inflammatory Drug), Postoperative Pain
Interventions: Naproxen 500 Mg, Ketorolac, OxyCODONE 5 mg Oral Tablet, Metaxalone 800 MG; Drug
Lead sponsor: Rothman Institute Orthopaedics; Other
Eligibility: 18 Years and older
Enrollment: 428 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Breast Cancer, Cancer Survivor, Fatigue, Pain
Interventions: exercise intervention, educational intervention, complementary or alternative medicine procedure, fatigue assessment and management, management of therapy complications, pain therapy, quality-of-life assessment; Behavioral · Other · Procedure
Lead sponsor: Clayton State University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2006
U.S. locations: 2
States / cities: Atlanta, Georgia • Morrow, Georgia

Conditions: Age-Related Macular Degeneration
Interventions: Loteprednol Etabonate Ophthalmic Gel [Lotemax], Refresh Lubricant Eye Drops [Artificial Tears]; Drug · Other
Lead sponsor: Virginia Polytechnic Institute and State University; Other
Eligibility: 18 Years and older
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Roanoke, Virginia

Conditions: Irritable Bowel Syndrome, Ulcerative Colitis, Inflammatory Bowel Disease
Interventions: Not listed
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 60 Years
Enrollment: 198 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Altitude Sickness
Interventions: Ibuprofen, Placebo; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 89 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010
U.S. locations: 1
States / cities: Stanford, California

Conditions: Systemic Lidocaine Improves Pain Control After Surgery by Attenuating the Systemic Inflammatory Response to Surgery
Interventions: IV lidocaine, Placebos; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 12 Years to 18 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Osteoarthritis Knee Pain
Interventions: Duloxetine, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 40 Years and older
Enrollment: 524 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 32
States / cities: Tucson, Arizona • Garden Grove, California • Long Beach, California + 29 more

Conditions: IUD Insertion Pain
Interventions: Ketorolac, Placebo; Drug
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older · Female only
Enrollment: 108 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Hillsborough, North Carolina

Conditions: Arthritis
Interventions: sodium citrate and citric acid; Drug
Lead sponsor: Texas Tech University Health Sciences Center, El Paso; Other
Eligibility: 21 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: El Paso, Texas

Search by objective public record fields.

Soy Tomato Juice to Improve Outcomes in Pancreatitis

A Study of ABT-652 in Combination With a Nonsteroidal Anti-Inflammatory Drug (NSAID) in Adults With Osteoarthritis Pain of the Knee

A Pilot Study to Assess the Safety, Tolerability, and Efficacy of Virtual Reality for the Treatment of Abdominal Pain in Quiescent Crohn's Disease

Ictal and Interictal Inflammatory Markers in Migraine

Postoperative Pain After Pediatric Adenotonsillectomy With Ketorolac or Ibuprofen

Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis

CBT-I for Sleep, Pain, and Inflammation in Crohn's Disease

Pain and Acetaminophen in Women Study

In Vitro Studies on Pharmacological Regulation and Genetic Risk Factors of Peripheral Human Nociceptors

Short-term Impact of Cyplexinol® on Self-reported Joint Pain

Study of Experimental Models of Pain and Inflammation.

Evaluation of Efficacy and Mechanisms of an Antiinflammatory Intervention for Chemotherapy Related Mucosal Injury

Control of Pain in Intravitreal Injections Using Topical NSAIDs

Precision Pain Management for Major Abdominal Surgery in Colorectal Surgery

Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures

Pain Control After Lumbar Spine Fusion

Exercise Program or Health Education Program in Reducing Fatigue and Pain in Breast Cancer Survivors

The Role of Loteprednol in Reducing Post-Intravitreal Injection Related Pain

Phenotyping IBS: Perceptions and Modulations of Visceral Sensations

Prevention of Altitude Illness With Non-steroidal Anti-inflammatory Study (PAINS)

IV Lidocaine in Pediatric AIS

A Study Comparing Duloxetine Versus Placebo in Patients Taking a Nonsteroidal Anti-inflammatory Drug (NSAID) for Knee Pain Due to Osteoarthritis

Oral Ketorolac for IUD Pain Reduction

Regulating Urine pH Levels to Alleviate Chronic Joint Pain